Home

Search

Pathway AI

Account ⋅ Sign Out

Table of contents

Deprescribing proton pump inhibitors

Key sources
The following summarized guidelines for the management of deprescribing proton pump inhibitors are prepared by our editorial team based on guidelines from the American Gastroenterological Association (AGA 2022) and the College of Family Physicians of Canada (CFPC 2017).
1
2

Guidelines

1.Medical management

Indications for discontinuation: consider discontinuing PPIs in all patients without a definitive indication for chronic use.
E
Show 2 more
Create free account

More topics in this section

  • Considerations for discontinuation

2.Patient education

General counseling: counsel patients discontinuing long-term PPI therapy that they may develop transient upper gastrointestinal symptoms due to rebound acid hypersecretion.
E

3.Follow-up and surveillance

Monitoring for indications: obtain a regular review (by the patient's primary care provider) of the ongoing indications for use and document that indication in all patients taking a PPI.
E